Viewing Study NCT01978366


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-02-02 @ 1:18 PM
Study NCT ID: NCT01978366
Status: TERMINATED
Last Update Posted: 2020-09-03
First Post: 2013-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Extension Study of HT-100 in Patients With DMD
Sponsor: Processa Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Duchenne muscular dystrophy View
None halofuginone hydrobromide View
None anti-fibrotic View
None anti-inflammatory View
None muscle regeneration View
None protein synthesis inhibitor View